bf/NASDAQ:TCRT_icon.jpeg

COM:ALAUNOS

Alaunos Therapeutics

  • Stock

USD

Last Close

2.32

22/11 21:00

Market Cap

9.61M

Beta: -

Volume Today

7.88K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
800K
-
1.37M
71.63%
4.33M
215.51%
6.86M
58.38%
6.39M
6.88%
146K
97.71%
398K
-
2.92M
634.17%
5K
99.83%
cost of revenue
740K
-
4.80M
-
gross profit
800K
-
1.37M
71.63%
4.33M
215.51%
6.86M
58.38%
6.39M
6.88%
146K
97.71%
-342K
-
2.92M
954.39%
-4.80M
264.20%
selling and marketing expenses
general and administrative expenses
15.66M
-
12.17M
22.32%
17.65M
45.05%
14.38M
18.53%
14.80M
2.93%
19.92M
34.60%
19.53M
1.96%
27.66M
41.68%
27.56M
0.37%
13.14M
52.32%
12.22M
7.02%
selling general and administrative expenses
15.66M
-
12.17M
22.32%
17.65M
45.05%
14.38M
18.53%
14.80M
2.93%
19.92M
34.60%
19.53M
1.96%
27.66M
41.68%
27.56M
0.37%
13.14M
52.32%
12.22M
7.02%
research and development expenses
42.85M
-
32.71M
23.68%
106.78M
226.50%
157.79M
47.77%
45.08M
71.43%
34.13M
24.29%
38.33M
12.30%
52.70M
37.48%
49.64M
5.79%
25.02M
49.60%
16.28M
34.93%
other expenses
-579K
-
-5K
99.14%
12K
340%
134K
1,016.67%
465K
247.01%
631K
35.70%
813K
28.84%
385K
52.64%
-1.20M
412.21%
529K
144.01%
971K
83.55%
cost and expenses
58.51M
-
44.87M
23.31%
124.43M
177.30%
172.17M
38.36%
59.88M
65.22%
54.05M
9.74%
57.86M
7.04%
80.36M
38.89%
77.21M
3.92%
38.16M
50.57%
34.27M
10.19%
operating expenses
58.51M
-
44.87M
23.31%
124.43M
177.30%
172.17M
38.36%
59.88M
65.22%
54.05M
9.74%
57.86M
7.04%
80.36M
38.89%
77.21M
3.92%
38.16M
50.57%
29.47M
22.78%
interest expense
-606K
-
-11.72M
1,833.66%
-12K
99.90%
-10K
16.67%
830K
8,400%
-789K
195.06%
1.18M
-
3.15M
166.84%
-1.92M
160.91%
ebitda
-58.16M
-
-55.22M
5.05%
-120.10M
117.49%
-165.18M
37.54%
-52.20M
68.40%
-54.06M
3.57%
2.89M
105.35%
-80.36M
2,877.77%
-76.07M
5.34%
-34.71M
54.37%
-34.27M
1.27%
operating income
-57.71M
-
-43.50M
24.63%
-120.10M
176.10%
-165.31M
37.64%
-53.49M
67.64%
-53.91M
0.77%
2.26M
104.20%
-80.36M
3,649.51%
-77.55M
3.50%
-35.10M
54.73%
-34.27M
2.39%
depreciation and amortization
738K
-
462K
37.40%
357K
22.73%
290K
18.77%
369K
27.24%
575K
55.83%
629K
9.39%
1.13M
79.33%
1.48M
31.21%
396K
73.24%
total other income expenses net
606K
-
11.72M
1,833.66%
12K
99.90%
10K
16.67%
-830K
8,400%
789K
195.06%
-120.06M
15,316.73%
385K
100.32%
-1.20M
412.21%
-2.63M
118.39%
-873K
66.74%
income before tax
-57.11M
-
-31.78M
44.35%
-120.09M
277.86%
-165.30M
37.65%
-54.32M
67.14%
-53.12M
2.22%
-117.80M
121.77%
-79.98M
32.11%
-78.75M
1.53%
-37.73M
52.09%
-35.14M
6.86%
income tax expense
-1.79M
-
-23.44M
1,208.82%
-12K
99.95%
114K
1,050%
2.13M
1,764.04%
-947K
144.56%
60.12M
6,448.68%
-1.13M
101.88%
-1.86M
64.63%
-133K
92.84%
net income
-57.11M
-
-31.78M
44.35%
-120.09M
277.86%
-165.30M
37.65%
-54.32M
67.14%
-53.12M
2.22%
-177.92M
234.95%
-78.85M
55.68%
-76.89M
2.48%
-37.60M
51.11%
-35.14M
6.54%
weighted average shs out
85.94M
-
101.13M
17.67%
125.42M
24.01%
130.39M
3.97%
136.94M
5.02%
143.51M
4.80%
167.95M
17.03%
209.64M
24.82%
214.40M
2.27%
217.13M
1.27%
16.00B
7,266.69%
weighted average shs out dil
85.94M
-
101.13M
17.67%
125.42M
24.01%
130.39M
3.97%
136.94M
5.02%
143.71M
4.95%
167.95M
16.87%
209.64M
24.82%
214.40M
2.27%
217.13M
1.27%
16.00B
7,266.69%
eps
-0.66
-
-0.31
53.03%
-0.96
209.68%
-1.27
32.29%
-0.40
68.50%
-0.37
7.50%
-1.06
186.49%
-0.38
64.15%
-0.36
5.26%
-0.17
52.78%
-0.00
98.71%
epsdiluted
-0.66
-
-0.31
53.03%
-0.96
209.68%
-1.27
32.29%
-0.40
68.50%
-0.37
7.50%
-1.06
186.49%
-0.38
64.15%
-0.36
5.26%
-0.17
52.78%
-0.00
98.71%

All numbers in USD (except ratios and percentages)